Elizabeth Gilbert

1.2k total citations · 1 hit paper
16 papers, 631 citations indexed

About

Elizabeth Gilbert is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elizabeth Gilbert has authored 16 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elizabeth Gilbert's work include Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Elizabeth Gilbert is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Elizabeth Gilbert collaborates with scholars based in United States. Elizabeth Gilbert's co-authors include Victoria Sherry, Faith Mutale, Christine Ciunci, Beth Eaby‐Sandy, John A. Kosteva, Gloria A DiLullo, Susan Stonehouse-Lee, Charu Aggarwal, Jeffrey C. Thompson and Joshua Bauml and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Urology.

In The Last Decade

Elizabeth Gilbert

16 papers receiving 627 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

2017 387 citations Stephen Bagley, Shawn Kothari et al. Lung Cancer profile →

Peers

Countries citing papers authored by Elizabeth Gilbert

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Gilbert more than expected).

Fields of papers citing papers by Elizabeth Gilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Gilbert. The network helps show where Elizabeth Gilbert may publish in the future.

Co-authorship network of co-authors of Elizabeth Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Gilbert. A scholar is included among the top collaborators of Elizabeth Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Gilbert. Elizabeth Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ 2022 ·Breast Cancer Research and Treatment ·Melissa Anne Mallory, Karissa Whiting, Anna Park, Mithat Gönen, Elizabeth Gilbert, Tari A. King, Melissa Pilewskie	2
2	Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ? 2020 ·Annals of Surgical Oncology ·Christina A. Minami, Emily C. Zabor, Elizabeth Gilbert, (unknown), Anna Park, Maxine S. Jochelson, Tari A. King, Melissa Pilewskie	11
3	The Tyrer–Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS 2019 ·Annals of Surgical Oncology ·Monica G. Valero, Emily C. Zabor, Anna Park, Elizabeth Gilbert, (unknown), Tari A. King, Melissa Pilewskie	29
4	Differences between screen-detected and interval breast cancers among BRCA mutation carriers 2019 ·Breast Cancer Research and Treatment ·Melissa Pilewskie, Emily C. Zabor, Elizabeth Gilbert, Michelle Stempel, Oriana Petruolo, Debra A. Mangino, Mark E. Robson, Maxine S. Jochelson	10
5	Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging 2018 ·Journal of Surgical Oncology ·Joseph G. Crompton, Elizabeth Gilbert, Mary S. Brady	7
6	P3.02c-029 Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab 2017 ·Journal of Thoracic Oncology ·Shawn Kothari, Stephen Bagley, Charu Aggarwal, Joshua Bauml, Evan Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Jeffrey C. Thompson, Susan Stonehouse-Lee, Victoria Sherry, Elizabeth Gilbert, Beth Eaby‐Sandy, Faith Mutale, Gloria A DiLullo, Roger B. Cohen, Anil Vachani, Corey J. Langer	9
7	P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) 2017 ·Journal of Thoracic Oncology ·Stephen Bagley, Shawn Kothari, Charu Aggarwal, Joshua Bauml, Evan Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Jeffrey C. Thompson, Susan Stonehouse-Lee, Victoria Sherry, Elizabeth Gilbert, Beth Eaby‐Sandy, Faith Mutale, Gloria A DiLullo, Roger B. Cohen, Anil Vachani, Corey J. Langer	4
8	Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer breakdown → 2017 ·Lung Cancer ·Stephen Bagley, Shawn Kothari, Charu Aggarwal, Joshua Bauml, Evan Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Peter Gabriel, Jeffrey C. Thompson, Susan Stonehouse-Lee, Victoria Sherry, Elizabeth Gilbert, Beth Eaby‐Sandy, Faith Mutale, Gloria A DiLullo, Roger B. Cohen, Anil Vachani, Corey J. Langer	387
9	Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance 2017 ·Annals of Surgical Oncology ·Elizabeth Gilbert, Emily C. Zabor, Michelle Stempel, Debra A. Mangino, Alexandra S. Heerdt, Melissa Pilewskie	23
10	P3.02c-069 Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC) 2017 ·Journal of Thoracic Oncology ·Stephen Bagley, Shawn Kothari, Charu Aggarwal, Joshua Bauml, Evan Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Jeffrey C. Thompson, Susan Stonehouse-Lee, Victoria Sherry, Elizabeth Gilbert, Beth Eaby‐Sandy, Faith Mutale, Gloria A DiLullo, Roger B. Cohen, Anil Vachani, Corey J. Langer	2
11	Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy 2017 ·The Journal of Urology ·Hao G. Nguyen, (unknown), Karla Lindquist, Vy Ngo, Elizabeth Gilbert, Henrik Bengtsson, Cristina Magi‐Galluzzi, (unknown), Jorge L. Yao, Matthew R. Cooperberg, Edward M. Messing, Eric A. Klein, Peter R. Carroll, Pamela L. Paris	4
12	An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer 2016 ·Cancer Letters ·Gayatri Premasekharan, Elizabeth Gilbert, Ross A. Okimoto, (unknown), Karla Lindquist, Vy Ngo, Ritu Roy, (unknown), Matthew R. Edwards, (unknown), Adam Foye, (unknown), (unknown), Matthew A. Gubens, Eric J. Small, Trever G. Bivona, Eric A. Collisson, Terence W. Friedlander, Pamela L. Paris	21
13	Applying Metrics to Outpatient Oncology Advanced Practice Providers. 2016 ·PubMed ·Elizabeth Gilbert, Victoria Sherry	2
14	Preliminary Results of a Phase Ib Study of Duvelisib in Combination with FCR (dFCR) in Previously Untreated, Younger Patients with CLL 2015 ·Blood ·Matthew S. Davids, Haesook T. Kim, Elizabeth Gilbert, (unknown), Karen Francoeur, (unknown), Jon Arnason, David C. Fisher, Jennifer R. Brown	11
15	Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC). 2014 ·Journal of Clinical Oncology ·Terence W. Friedlander, Gayatri Premasekharan, Vy Ngo, (unknown), (unknown), Michael B. Winter, Elizabeth Gilbert, Charles S. Craik, Pamela L. Paris	2
16	Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer 2013 ·International Journal of Cancer ·Terence W. Friedlander, Vy Ngo, Huan Dong, Gayatri Premasekharan, Vivian Weinberg, (unknown), Qiang Zhao, Elizabeth Gilbert, Charles J. Ryan, Wen‐Tien Chen, Pamela L. Paris	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact